CurrentBlue Cross Blue Shield - New MexicoPolicy CPCPLABO29

Intracellular Micronutrient Analysis

This BCBSNM clinical payment and coding policy governs reimbursement for intracellular micronutrient panel testing (e.g., SpectraCell, Cell Science Systems, ExaTest) and applies to providers submitting claims to Blue Cross Blue Shield of New Mexico.

Policy Summary

PayerBlue Cross Blue Shield - New Mexico

PolicyIntracellular Micronutrient Analysis

Policy CodePolicy CPCPLABO29

Change TypeNo material change

Effective DateJan 1, 2023

Next Review Date

Key ActionProviders must submit claims with accurate documentation using valid HIPAA-approved code sets and may need to provide additional documentation upon request.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

not reimbursableintracellular micronutrient panel testing status

Version 1.0policy version

01/01/2023plan effective date

list presentCPT/other codes referenced

Coverage Determination

Intracellular micronutrient testing coverage

Covered when ALL of the following are met:

ALL of the following

Intracellular micronutrient panel testing, including but not limited to SpectraCell; Cell Science Systems cell micronutrient assay and ExaTest, is not reimbursable.

Referenced Codes

Referenced CPT/HCPCS codesCPTNot Covered

82128
82136
82180
82310
82379
82495
82525
82607
82652
82725

1–10 of 13

1/2

Provider Responsibilities and Payer Discretion

Policy Summary

PayerBlue Cross Blue Shield - New Mexico

PolicyIntracellular Micronutrient Analysis

Policy CodePolicy CPCPLABO29

Change TypeNo material change

Effective DateJan 1, 2023

Next Review Date

Key ActionProviders must submit claims with accurate documentation using valid HIPAA-approved code sets and may need to provide additional documentation upon request.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Documentation Required

Provider documentation and claims submission

Providers are responsible for submission of accurate documentation of services performed. Submit claims using valid HIPAA-approved code sets and code appropriately per industry-standard coding guidelines (for example: UB, AMA CPT, HCPCS, ICD-10-CM/PCS, NDC, DRG, CMS NCCI policy manual and CCI table edits). Claims are subject to code edit protocols and review for correct coding, medical necessity, benefit coverage, provider contract terms, applicable medical policies, clinical payment and coding policies, and any coding software logic. Upon request, the provider must furnish additional documentation to support the claim.

Use HIPAA-approved code sets (CPT, HCPCS, ICD-10, NDC, DRG)
Follow AMA CPT, CMS NCCI/CCI, UB and other industry coding guidance
Provide additional documentation upon request to support coding and medical necessity

Note

Payer discretion

BCBSNM may use reasonable discretion in interpreting and applying this policy to services in particular cases. If a conflict exists between this Clinical Payment and Coding Policy and a member's plan document, the plan document governs. If a conflict exists between this policy and a provider contract, the provider contract governs. BCBSNM has full and final discretionary authority for interpretation and application of this policy to the extent allowed by applicable plan documents.

Policy interpretation and application are subject to plan documents and provider contracts
BCBSNM retains discretionary authority consistent with plan terms

Key Definitions

Intracellular micronutrient panel testing

DefinitionIntracellular micronutrient panel testing (examples include SpectraCell, Cell Science Systems cell micronutrient assay, ExaTest) is laboratory testing that analyzes cellular nutrient status and is identified in this policy as not reimbursable.

Policy stanceNot reimbursable — Intracellular micronutrient panel testing is excluded from reimbursement under this policy.

ExamplesNamed examples include SpectraCell, Cell Science Systems cell micronutrient assay, and ExaTest.

ScopeApplies to providers submitting claims to Blue Cross Blue Shield of New Mexico; reimbursement for these tests will not be provided per this policy.